RecruitingNot ApplicableNCT07196488

Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses

Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses

Sponsor

National Taipei University of Nursing and Health Sciences

Enrollment

60 participants

Start Date

Oct 13, 2025

Study Type

INTERVENTIONAL

Conditions

Prostate Cancer (Adenocarcinoma)

Summary

This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week "Dyadic Co-learning Intervention," which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Participants will be randomly assigned to one of two groups. One group will receive regular care, while the other group will receive regular care plus the new co-learning program. The investigators will ask both patients and their spouses to complete questionnaires at the beginning of the study, and again at 10 and 16 weeks, to understand how the program affects their health and well-being.

Eligibility

Min Age: 20 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a joint education program designed for prostate cancer patients and their spouses to learn together about the disease, treatment options, and how to cope. The goal is to improve both the patient's and partner's understanding and emotional wellbeing. **You may be eligible if...** - You are a man diagnosed with prostate cancer who has decided on a treatment plan or completed treatment within the past two years - You are in generally good physical health (able to carry out daily activities) - You are a spouse who lives with the patient and is 20 years or older and physically independent **You may NOT be eligible if...** - Either the patient or spouse has been diagnosed with another type of cancer - Either the patient or spouse has cognitive impairment, dementia, depression, or anxiety Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDyadic Co-learning Intervention

Participants in the experimental group will receive routine care plus an 8-week Dyadic Co-learning Intervention, which will consist of three components: (1) a co-learning handbook, (2) a co-learning mobile app, and (3) professional support.

Locations(2)

Keelung Chang Gung Memorial Hospital

Keelung, Taiwan

LinKou Chang Gung Memorial Hospital

Taoyuan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07196488

Related Trials

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

NCT075529221 location

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

NCT068443832 locations

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

NCT0748497124 locations

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

NCT06592924340 locations

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

NCT068012368 locations